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Abstract
Krista L. Herbert
MHEALTH FOR THE TREATMENT OF DEPRESSION IN PRIMARY CARE: A
FEASIBILITY STUDY
2020-2021
Jim A. Haugh, Ph.D.
Doctor of Philosophy

The primary aim of this study was to evaluate the feasibility and acceptability of
using mobile applications (apps) designed to ameliorate depressive symptoms in primary
care. The secondary aim was to examine whether participants utilizing a mobile app
would experience reductions in depressive symptoms and improvements in quality of
life. Recruitment was conducted in two primary care practices. Participants who agreed
to be part of the trial completed measures of depressive symptoms and quality of life at
baseline, post-treatment, and a one-month follow-up. Measures of acceptability and
feasibility were also gathered throughout the study duration. Results provided partial
support for the feasibility of conducting such a trial on a larger scale. However, specific
difficulties in recruitment were noted that warrant correction in additional trials. On the
other hand, individuals who did use the apps were retained across the study duration,
reported a reduction of depressive symptoms at post-intervention, and found the
intervention acceptable. Additionally, improvements in certain areas of quality of life,
such as energy level, fatigue, and emotional well-being at post-intervention were also
reported. Together, the results provide preliminary evidence in support of the
acceptability and effectiveness of using mobile apps in a primary care setting.
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Chapter 1
Introduction
Primary care has become the first point of contact for a majority of individuals
experiencing depressive symptoms (Kessler & Stafford, 2008). It is estimated that 5 to
13% of patients seen by primary care providers are diagnosed with major depressive
disorder, while the 12-month prevalence of depressive symptoms in primary care is
12.5% (Mitchell et al., 2009; Pignone et al., 2002). According to Moussavi et al. (2007),
individuals with a history of depression endorse lower scores on measures of overall
health when compared to those diagnosed with cardiovascular disease, asthma, arthritis,
or diabetes. Further, symptoms of depression not only impact an individual's functionality
in terms of missed work and reduced productivity (Wang et al., 2004), but those
diagnosed with depression are more likely to report poorer overall physical health and
experience higher rates of comorbid chronic diseases (Katon, 2003; Kessler & Stafford,
2008). As a result, individuals diagnosed with depression utilize a significantly greater
amount of healthcare services and emergency room visits when compared to
nondepressed individuals (Kessler & Stafford, 2008). Of the $201 billion spent on mental
health disorders in 2013, $98.9 billion were spent on treating major depressive disorder
(MDD) alone (Greenberg et al., 2015).
The standard of care for treating depression within primary care typically involves
prescribing antidepressant medication, referral for outpatient psychotherapy, or some
combination of these two treatments (Trangle et al., 2016). However, many patients do
not adhere to treatment recommendations, discontinue treatment prematurely, or do not
respond to antidepressants or psychotherapy (Kessler & Stafford, 2008; Sansone &
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Sansone, 2012; Trangle et al., 2016). Additionally, these treatments may be too intensive
for individuals with less severe depressive symptomatology. Given the problems
associated with treating depression in primary care, alternative modes of treatment
delivery have been proposed to increase the efficiency, accessibility, and effectiveness of
mental health services.
One alternative to traditional, clinic-based care is the use of less intensive, more
personalized mHealth interventions, which include mobile applications (apps). Mobile
apps have distinct advantages over traditional mental health interventions, including
lower costs, increased treatment accessibility, and greater retention (Donker et al., 2013).
Additionally, these apps are generally available at little to no cost and can circumvent the
stigmas associated with receiving professional help for psychological symptoms. Further,
mobile apps provide individuals with the opportunity to track and monitor their
symptoms and progress in real-time, which is a more accurate representation of their
experience of symptoms and impact on daily life (Donker et al., 2013; Proudfoot et al.,
2010). Thus, if individuals can monitor and track their symptoms and progress, they may
be more inclined to adhere to the recommended treatment (Proudfoot et al., 2010). These
advantages have led to the rapid development of mobile apps in recent years, with one
recent review reporting the existence of over 1,000 apps available for the management of
depression (Shen et al., 2015).
Numerous studies have examined the impact of using mobile apps on depression.
One way in which researchers have explored the effectiveness of apps is by investigating
whether individuals who utilize an app experience a statistically significant reduction of
depressive symptoms. Preliminary evidence suggests that using mobile apps can reduce
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depressive symptoms. For example, in their meta-analysis of 18 randomized controlled
trials with 22 mobile apps, Firth et al. (2017) found that individuals using mobile apps to
manage depressive symptoms experienced a significant reduction of symptoms when
compared to control conditions (g=0.38, p<0.001). The authors reported moderate effect
sizes compared to inactive control groups (g=0.56) and small effect sizes compared to an
active control condition (g=0.22). In a large scale randomized controlled trial, Moberg et
al. (2019) found that participants utilizing the mobile app Sanvello (i.e., Pacifica)
experienced greater decreases in depression (d=0.54, p<.001), anxiety (d=0.40, p<.01),
and the Depression Anxiety and Stress Scales-21 (DASS-21) scores (d=0.46, p<.001) at
4-weeks post-intervention when compared to the waitlist control condition.
Another way of defining outcome is through examining remission rates or
clinically significant reductions of depressive symptoms. While definitions of remission
rates vary across studies, evidence suggests that some individuals experience remission of
depressive symptoms when utilizing mobile apps. Arean et al. (2016) evaluated remission
rates, as defined by a reduction of pre-treatment Patient Health Questionnaire-9 (PHQ-9)
scores of at least 50%, in three self-guided mobile apps: a problem-solving application, a
cognitive training application, and a health information application, which served as the
active control group. Results indicated that 45 out of the 100 participants (45%)
randomized to the cognitive training application and 36 out of 79 participants (46%)
randomized to the problem-solving therapy app experienced a remission of symptoms. In
comparison, 34 out of 100 participants (34%) of the control condition participants
experienced remission. Pratap et al. (2018) evaluated recruitment, engagement, and
remission rates of individuals experiencing depressive symptoms, utilizing the same
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conditions as Arean and colleagues. In this study, remission was defined as a decrease in
PHQ-9 scores of at least 5 points or more from baseline. They found 117 out of 345
participants (34%) experienced a remission of symptoms. However, results also indicated
that 51% of participants were "nonresponders" (i.e., experiencing a change in PHQ-9
scores of <5 points), and 11% experienced an increase in depressive symptomology.
In addition to examining whether apps can reduce depressive symptoms or cause
a remission of symptoms, studies have also explored whether the severity of symptoms
one experiences influences the effectiveness of mobile apps. Results from these studies
are mixed. For example, a recent meta-analysis revealed moderate effect sizes (g=0.51)
for individuals with self-reported mild to moderate depressive symptoms, suggesting that
mobile apps may be most effective for this subsample of depressed patients (Firth et al.,
2017). In contrast, Pratap et al. (2018) found that changes in depressive symptomology
were significantly associated with baseline severity of symptoms, in that participants who
endorsed severe depressive symptoms experienced the greatest reduction of depressive
symptoms during the first four weeks of treatment (beta=4.19, p<.001). The findings
from Pratap et al. (2018) not only stand in contrast to results from Firth et al. (2017) but
also to the existing self-help literature, which recommends the use of self-help
interventions for mild to moderate depressive symptoms (Clarke et al., 2009; Cuijpers et
al., 2010). Therefore, they may need further replication.
A more recent question being explored in the literature is related to the long-term
effects of mobile apps for depression. Results from these studies are also mixed. For
instance, Arean et al. (2016) found no significant changes in PHQ-9 scores at the 12week follow-up. Similarly, Pratap et al. (2018) found no significant reductions of PHQ-9
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scores across conditions at the 12-week follow-up. On the other hand, Moberg et al.
(2019) found that two months post-intervention, the rates of clinically significant changes
for participants in the Pacifica condition was 35% for the PHQ-8 (compared to 42% at
four weeks-post baseline). Given the issues with retention and engagement in both Arean
et al. (2016) and Pratap et al.'s (2018) studies, the long-term effects of mobile apps may
be related to one's engagement with the mobile app.
While the results from these studies indicate that mobile apps have the potential to
effectively treat depressive symptoms, there are several gaps within the current literature.
First, most mobile apps currently available to the general public have been inadequately
evaluated for their effectiveness in treating depressive symptoms (Donker et al., 2013;
Firth et al., 2017). For example, Martinez-Perez et al. (2013) found that out of the 1,536
depression apps available to the general public, only 32 published articles evaluated the
effectiveness of depression apps.
Second, many of the published studies have been plagued with retention and
engagement issues; however, it is unclear what factors contribute to these issues and the
user end experience of utilizing a mobile app. For example, Arean et al. (2016) reported
that 58% of the 626 participants did not download either of the two intervention apps.
Those who did download and use the app, only used the mobile app an average of eleven
times over the course of four weeks. Pratap et al. (2018) successfully enrolled 1040
participants; however, only approximately 34% (348 out of 1040) were active in the
study, as defined by completing at least one PHQ-9 measure. Furthermore, by week 4 of
the study, approximately 50% of participants dropped out. Given these issues with
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engagement and retention, it is important to understand factors that might motivate app
engagement and prolong app usage.
Third, the studies to date have neglected to examine patient preferences towards
specific mobile apps. Mobile apps offer more flexibility than routine clinical care, as
patients can select mobile apps based on their individual preferences. Additionally, there
is evidence to suggest that primary care patients have specific preferences regarding the
type of psychotherapy they would prefer to receive (e.g., cognitive therapy, behavioral
activation, problem-solving therapy, interpersonal psychotherapy, and mindfulness) if
they were to seek treatment for depression (Haugh et al., 2019). Specifically, Haugh et al.
(2019) conducted a cross-section survey to assess the acceptability of the stepped care
model of depression treatment and treatment preferences in a group of primary care
patients. Results indicated that participants most frequently preferred cognitive therapy
(28%, n=26), followed by problem-solving therapy (25%, n=24), mindfulness (18%,
n=17), behavioral activation (17%, n=16), and interpersonal (12%, n=11). Further,
numerous studies have indicated that incorporating patient treatment preferences
throughout treatment improves clinical outcome (Firth et al., 2015; Lin et al., 2005; Swift
& Callahan, 2009), increases adherence (Kwan et al., 2010), and reduces rates of attrition
(Swift & Greenberg, 2015). Thus, examining patient preference for mobile apps might
help us understand factors that could enhance treatment outcomes.
Finally, these apps have yet to be examined within the context of primary care.
Due to the barriers of accessing mental health care, the potential costs of untreated or
inadequately treated depression, and existing gaps in the literature regarding the modest
quantity and poor quality of most empirical evidence to date, it is necessary to explore
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mobile apps for treating depression in primary care settings. Through such research, we
might improve the accessibility, efficiency, and effectiveness of mental health services
within primary care.
Therefore, this study's primary aim is to evaluate the feasibility and acceptability
of implementing three mobile apps designed to ameliorate depressive symptoms within
primary care. Specifically, this study aims to evaluate the feasibility of recruitment,
randomization, retention, assessment procedures, and participant engagement with the
mobile apps. Participants will be randomized, with a 1:1:1:1 allocation, to receive a)
MoodTools, a cognitive behavioral therapy app, b) Moving Forward, a problem-solving
therapy app, c) Mindfulness Coach, a mindfulness-based app, or d) the waitlist control
condition. Regarding acceptability, previous research suggests that both patients and
physicians in primary care find these mobile delivery methods acceptable (Haugh et al.,
2019). Furthermore, most patients in that sample (44%, n=57) reported if they were to
seek treatment for depressive symptoms, they would prefer to begin treatment with a selfhelp intervention, specifically delivered via a mobile app.
The secondary aim is to examine whether participants utilizing a mobile
application will experience a reduction of depressive symptomology and improvements
in quality of life when compared to a waitlist control condition. Based on previous
literature, we hypothesize that patients utilizing mobile apps will show a clinically
significant reduction in depressive symptoms and improved quality of life when
compared to the waitlist control condition.
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Chapter 2
Method
Participants
Participant characteristics (N=3) are displayed in Table 1.

Table 1
Participant Characteristics
Variable

Participant 1

Participant 2

Participant 3

Age

21

33

27

Gender Identity

Man

Woman

Woman

Marital Status

Prefer not to
answer

Never married

Married

Race

White

White

White

Ethnicity

Prefer not to
answer

NonHispanic/Latinx

NonHispanic/Latinx

Education

Associate Degree

Associate Degree

Associate Degree

Employment Status

Full-time

Part-time

Full-time

Income

$25,000-$49,000

Less than $14,999

$25,000-$49,000

Insurance

Medicare only

Medicaid

Private or
commercial
insurance

Medication

--

Zoloft

Lexapro &
Wellbutrin

Length

--

3 years

2 years

8

Variable

Participant 1

Participant 2

Participant 3

Previous
Psychotherapy

No

Yes

Yes

How long ago did you -receive psychotherapy
for depression?

3 or more years ago

3 to 6 months ago

Satisfaction with
Treatment

--

Somewhat satisfied

Somewhat satisfied

Do you believe that
the treatment you
received was helpful?

--

Somewhat agree

Somewhat agree

During the past 12
-months, was there any
time when you
needed mental health
treatment but did not
get it?

No

Yes

Reasons for not
seeking treatment

--

The hours were not
convenient

--

Group Assignment
Participants one and two were randomized to the Mindfulness Coach app, and
participant three was randomized to the MoodTools App. Due to low enrollment rates,
there were no participants randomized to the waitlist control condition as initially
planned.
Setting and Procedure
Participants were recruited between August 25, 2019 and March 12, 2020 from
two Family Medicine clinics affiliated with the School of Osteopathic Medicine at
Rowan University. Due to the COVID-19 pandemic, recruitment for this project was

9

prematurely terminated on March 15, 2020. At that time, Rowan University required all
students to cease all in-person data collection that would put them in direct contact with
the public. Additionally, the Family Medicine clinics affiliated with the School of
Osteopathic Medicine only allowed essential employees in the facility and did not allow
in-person recruitment for research protocols. When the first author left for a doctoral
internship in June of 2020, these policies remained.
Eligibility Criteria
Initial eligibility criteria required participants to (1) be at least 18 years of age or
older, (2) own an iPhone with Wi-Fi or 3G/4G capabilities, and (3) obtain a score
between five and fourteen on the nine-item Patient Health Questionnaire (PHQ-9). For
those who were managing their depression through psychotropic medication, their
medication regimen must have been stable for six weeks. This information was
confirmed through the patient and their primary healthcare provider.
Participants were deemed ineligible if they (1) scored fifteen or higher on the
PHQ-9 at prescreening, (2) were actively suicidal or exhibiting suicidal ideation (as
determined by an endorsement of one or higher on item 9 on the PHQ-9 at prescreening),
(3) were receiving psychotherapy (by self-report), (4) were pregnant (by self-report), or
(5) had a self-reported history of bipolar disorder, substance use disorder, dementia,
neuro-developmental disorders, or schizophrenia spectrum disorders. Before approaching
a patient, a member of the research team asked their primary care provider if the patient
had a history of the psychiatric diagnoses mentioned above.
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Recruitment
Participants were prescreened using the PHQ-9. Yearly administration of this
instrument was already a routine practice at these locations. The certified medical
assistants notified a member of the research team of patients who scored between five
and fourteen on the PHQ-9. A member of the research team approached those patients
following their visit with their provider to explain the study, assessed interest and
eligibility, and completed informed consent. After informed consent, participants
completed the baseline survey. The first section of the baseline survey comprised
questions inquiring about sociodemographic information, mental health treatment history,
barriers to engaging in mental health treatment, treatment preferences, and health service
utilization. Additionally, participants completed the following measures: The Patient
Health Questionnaire-8 (PHQ-8), Self-Report Quality of Life (SF-36), The Five Facet
Mindfulness Questionnaire (FFMQ), The Social Problem-Solving Inventory-Revised:
Short Form (SPSI-R: SF), and the Automatic Thoughts Questionnaire-Negative (ATQN). The survey was administered through Qualtrics, an online survey platform, via an
iPad.
After completing the baseline assessment, all participants were then randomized
with a 1:1:1:1 allocation to receive a) MoodTools, a cognitive behavioral therapy app, b)
Moving Forward, a problem-solving therapy app, c) Mindfulness Coach, a mindfulnessbased app, or d) the waitlist control condition. Participants randomized to the waitlist
control condition would be informed that they would have access to the mobile apps after
completing the final study survey. They would also be given the opportunity to be reentered into the study using their most preferred mobile application.
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For participants randomized to a mobile app condition, a member of the research
team helped all participants download the mobile application and provided brief training
(~10 minutes) on the mobile application's specific features and how to use the mobile
application effectively. Participants were also provided with a link to an instructional
YouTube video created by the study coordinator on the app's specific features and how to
use it effectively. Participants were encouraged to use the mobile app daily but were
asked to use it at least once per week.
Participants were contacted via email weekly by the research study coordinator to
help with any difficulties or problems encountered when using the mobile application.
Within that email, participants were provided with a link to a brief Qualtrics survey
containing the PHQ-8 and two questions inquiring about how often they use the mobile
app (i.e., "How many days per week, on average, did you use the app" and "On average,
how many total minutes do you spend using the app per day").
All measures were completed via Qualtrics. Outcomes were assessed at three time
points: baseline, post-treatment (i.e., six weeks later), and follow-up (i.e., ten weeks after
baseline). The post-treatment and follow-up surveys comprised the same questions and
measures as the baseline, except for questions inquiring about sociodemographic
information, mental health treatment history, barriers to engaging in mental health
treatment, and treatment preferences. Additionally, for participants who were randomly
assigned to an app condition, the post-treatment survey included questions about the
acceptability of and satisfaction with the mobile app used throughout the study.
Participants received compensation for each survey packet they returned.
Specifically, participants were given a $10 gift card for completing the baseline survey, a
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$15 gift card for completing the post-treatment survey, and a $20 gift card for completing
the follow-up survey (total possible compensation for completion of all surveys was $45).
The University's Institutional Review Board approved this study.
Mobile Apps
The mobile apps used in this study were chosen based on their consistency with
evidence-based treatments for depression as outlined on the American Psychological
Association's Society for Clinical Psychology's website (Society for Clinical Psychology,
2020) and those endorsed by the American Academy of Family Medicine (Rebebrew,
2018). Clinical practice guidelines for treating depression recommend the use of
empirically supported treatments, including behavioral therapy, cognitive therapy,
cognitive-behavioral, mindfulness-based cognitive therapy, interpersonal psychotherapy,
psychodynamic psychotherapies, and problem-solving therapy (American Psychological
Association, 2019; Society for Clinical Psychology, 2020). Based on the apps available
within the Apple app store, three treatments were selected: cognitive-behavioral, social
problem-solving, and mindfulness. We then selected three apps based on their
consistency with the underlying theory, ease of use, design quality, and cost (i.e., free).
The cognitive-behavioral-based app, MoodTools (version 1.6), was created by
Inquiry Health LLC. MoodTools provides users with information on the components of
cognitive-behavioral therapy. The application focuses on teaching individuals how to
monitor and challenge maladaptive beliefs and increase engagement in previously
enjoyable activities. The social problem-solving app, Moving Forward (version 1.3), was
created by the Department of Veterans Affairs and the Department of Defense. This
application was designed to help individuals identify their problem-solving style,
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understand factors that inhibit problem-solving abilities, teach patients how to effectively
solve problems, and provide the ability to track progress over time. The mindfulnessbased app, Mindfulness Coach (version 2.3), was created by the Department of Veterans
Affairs. This application focuses on teaching individuals how to engage in mindfulness
practice. The application provides users with information on mindfulness, 21 audioguided mindfulness exercises, and allows users to track their progress over time.
Measures
Participants were asked to indicate their gender identity, age, marital status, racial
identity, ethnicity, level of education, employment status, and income. Participants were
also asked to provide information regarding their current health insurance status, prior
engagement in psychotherapy, and prior and current psychopharmacological treatment.
The following variables were also measured.
Treatment Preference
Participants were asked to indicate their strength of preference for the mobile
application on a 5-point Likert scale ranging from 1 (Not strong) to 5 (Very strong). Prior
to this, they were provided with a brief overview of problem-solving therapy, cognitivebehavioral therapy, and mindfulness and asked to indicate which of those treatments they
would prefer and the strength of that preference.
Barriers to Mental Health Treatment
One question from the National Comorbidity Survey Replication (Mojtabi et al.,
2011) regarding reasons for not seeking mental health treatment was included in this
survey. More specifically, participants were asked, "During the past 12 months, was there
any time when you needed mental health treatment or counseling for yourself but did not
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get it?" If participants answered "yes" to this question, they were then able to select from
a list of 14 statements that included reasons involving structural barriers (e.g.,
transportation, financial/insurance concerns), low perceived need for treatment, the desire
to handle the problem on their own, the presence of stigma, and concerns that therapy or
counseling would not be helpful.
Feasibility
In accordance with recommendations from Leon et al. (2011), feasibility was
assessed through the following variables: number of participants screened per month;
number enrolled per month; the proportion of those eligible participants who enrolled in
the study; participant adherence to the protocol, as measured through self-reported daily
use of the app; the proportion of planned assessments completed by participants; and
duration of assessments.
Acceptability
Acceptability was assessed via a self-report measure created by the author. These
questions were modified from Arigo et al. (2015). Participants were surveyed about their
satisfaction with the application, perceived effectiveness, the likelihood of participating
in the study again, whether they would recommend the application to a friend or family
member with depression, and level of confidence regarding future use of the app and use
of specific skills. Items were rated on a 5-point Likert scale. Participants were also
encouraged to provide written feedback about the mobile app features they liked the most
and least, specific ways in which the mobile app helped them manage depressive
symptoms, recommendations for improvements, and whether they still needed assistance
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managing specific depressive symptoms. This measure contains a total of 12 items. See
Appendix A for the full measure.
Health Service Utilization
Health service utilization was evaluated using a self-report measure created by the
author. Participants were asked to indicate how often they used specific health care
services (i.e., medical/specialty services, primary care, emergency department, and
psychiatry services) in the past month and the purpose of those visits. This measure
consisted of 10 items. See Appendix B for the full measure.
The Patient Health Questionnaire-9 (PHQ-9)
The PHQ-9 is a 9-item self-report questionnaire that assesses each of the DSM-5
criteria for Major Depressive Disorder (MDD; Kroenke et al., 2001). Items are rated on a
4-point Likert scale, ranging from 0 (not at all) to 3 (nearly every day). Total scores on
the PHQ-9 range from 0 to 27, and a total score of 10 or greater is used as a clinical cutoff for the indication for a probable DSM-5 diagnosis of MDD. The PHQ-9 has high
sensitivity (88%) and specificity (88%); (Kroenke et al., 2001) and excellent validity and
reliability (Kroenke et al., 2001).
The Patient Health Questionnaire-8 (PHQ-8)
The PHQ-8 is an 8-item self-report questionnaire that assesses eight of the nine
DSM-5 criteria for Major Depressive Disorder (MDD; Kroenke et al., 2009). The ninth
item, which assesses thoughts of death and self-harm, is omitted. Items are rated on a 4point Likert scale, ranging from 0 (not at all) to 3 (nearly every day). Total scores on the
PHQ-8 range from 0 to 24, and a total score of 10 or greater is used as a clinical cut-off
for the indication for a probable DSM-5 diagnosis of MDD (Kroenke et al., 2009).
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Treatment recommendations for individuals who endorse scores between five and
fourteen include watchful waiting, education, self-management, psychotherapy, or
medication (DeJesus et al., 2007). Individuals who endorsed scores of fifteen or higher
warrant treatment for depression using antidepressant medication, psychotherapy, or a
combination of the two (DeJesus et al., 2007). Therefore, these individuals proceeded
with the level of care recommended by their primary care provider.
36-Item Short Form Health Survey (SF-36)
The SF-36 is a 36-item self-report questionnaire that assesses health status and
quality of life (McHorney et al., 1993). The SF-36 consists of eight subscales that are
intended to measure health-related quality of life: the physical functioning subscale
consists of 10 items, the role limitations due to physical health subscale consists of 4
items, the role limitations due to emotional problems subscale consists of 3 items, the
energy/fatigue subscale consists of 4 items, the emotional well-being subscale consists of
5 items, the social functioning subscale consists of 2 items, the pain subscale consists of 2
items, and the general health subscale consists of 5 items. Items are rated on a Likertscale, with some items rated on a 5 or 6-point scale and others on a 2 or 3-point scale.
The eight subscales demonstrate excellent reliability, with alpha coefficients of .93, .84,
.83, .86, .90, .85, .78, and .78, respectively (McHorney et al., 1993).
As part of a larger project, participants also completed the following measures.
The Five Facet Mindfulness Questionnaire (FFMQ)
The FFMQ is a 39-item self-report questionnaire developed to assess mindfulness
skills (Baer et al., 2006). Baer et al. (2006) used exploratory factor analysis to examine
the facet structure of five independently developed self-reported mindfulness
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questionnaires: The Mindful Attention Awareness Scale, The Freiburg Mindfulness
Inventory, The Kentucky Inventory of Mindfulness Skills, The Cognitive and Affective
Mindfulness Scale, and The Mindfulness Questionnaire. Results from the exploratory
factor analysis yielded five independent, yet related, facets of mindfulness: the Observe
subscale consists of 8 items, the Describe subscale consists of 8 items, the Acting with
Awareness subscale consists of 8 items, the Nonjudging of inner experience subscale
consists of 8 items, and the Nonreactivity to inner experience subscale consists of 7
items. Items are rated on a 5-point Likert scale, ranging from (1) never or very rarely true
to (5) very often or always true. The five separate subscales, Observe, Describe, Acting
with Awareness, Nonjudging of inner experience, and Nonreactivity to inner experience
demonstrate high internal consistency (Cronbach's alpha = .83, .91, .87, .87, and .75,
respectively; Baer et al., 2006).
The Social Problem-Solving Inventory-Revised: Short Form (SPSI-R: SF)
The SPSI-R: SF is a 25-item self-report questionnaire that assesses two kinds of
problem-solving orientations and three problem-solving styles (D'Zurilla et al., 2002).
Items are rated on a 5–point Likert, ranging from (0) not at all true of me to (4) extremely
true of me. The SPSI-R-SF measures all five dimensions of the social problem-solving
model, including Positive Problem Orientation (PPO; 5 items), Negative Problem
Orientation (NPO; 5 items), Rational Problem-solving Style (RPS; 5 items), Impulsive–
Careless Style (ICS; 5 items), and Avoidance Style (AS; 5 items). The SPSI-R-SF
demonstrates high internal consistency (Cronbach's alpha = .93) and test-retest reliability
(r=.84) for the total score. The five separate subscales (PPO, NPO, RPS, ICS, and AS)
demonstrate moderate to high internal consistency (Cronbach’s alpha = .79, .80, .88, .78,
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and .89 respectively) and adequate test re-test reliability (r=.72, .79, .74, .72, and .73,
respectively, D’Zurilla et al., 2002) in young adult and adult samples.
Automatic Thoughts Questionnaire –Negative (ATQ-N)
The ATQ-N is a 30-item self-report questionnaire that assesses the frequency of
negative automatic cognitions associated with depressive symptoms (Hollon & Kendall,
1980). Items are rated on a 5–point Likert scale, ranging from (1) not at all to (5) all the
time. Total scores range from 30 to 150. The ATQ-N demonstrates high internal
consistency (Cronbach’s alpha = .96; Hollon & Kendall, 1980).
Data Analyses
Data analyses were conducted using IBM SPSS 27 and Microsoft Excel 2020 for
graphical representations of data. Descriptive analyses are used to present the frequency
and duration of app use, completion time of study surveys, and acceptability of the
mobile apps. Individual participant changes in depressive symptoms and self-reported
quality of life are depicted graphically.
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Chapter 3
Results
Feasibility
Establishment of the Research Team
The research team comprised a full-time faculty member within the Psychology
Department at Rowan University, a Licensed Clinical Psychologist and Physician from
the Department of Family Medicine, two advanced level doctoral students, one
undergraduate research assistant, and one post-baccalaureate research assistant.
Recruitment Team. Recruitment was completed by one doctoral-level student,
one undergraduate research assistant, and one post-baccalaureate research assistant.
Recruitment team members were available for recruitment for a total of 16 hours per
week. The licensed clinical psychologist and physician from the Department of Family
medicine prescreened potential patients at the beginning of each week for the research
assistants to approach.
Primary Care Office Staff. The primary care staff comprised family medicine
residents, physicians, nurse practitioners, and certified medical assistants.
Screening and Recruitment
Screening and recruitment data are displayed in Figure 1. Approximately 5.33
patients were screened per month, resulting in 35 potential participants. Over a six-month
period, 35 primary care patients were screened, and three were enrolled, resulting in an
8.6% screening to enrolled ratio. Of those not enrolled, sixteen did not meet the inclusion
criteria, seven declined to participate, three did not finish screening, and six patients
could not be contacted after expressing interest in the study. As displayed in Figure 1,
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two participants were randomized to the Mindfulness Coach condition and one
participant was randomized to the MoodTools condition. No participants were
randomized to the MovingForward or Waitlist Control conditions because of initial low
enrollment. However, and most importantly, pandemic circumstances precluded
additional data collection.

Figure 1
Consolidated Standards of Reporting Trials (CONSORT) Diagram
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Retention Rates & Treatment Adherence
As displayed in Figure 1, all three participants completed the 6-week intervention
and the post-treatment survey, yielding a 100% retention rate. Participants were
encouraged to use the mobile app daily but were asked to use it at least once per
week. Participants' app use (i.e., days per week and minutes per day) is presented in
Table 2.

Table 2
Participants' Mobile App Use
Participant Onea
Survey
App Use (Average days per week)
Minutes per use
Week 1
Rarely (1 Day)
7
Week 2
Some of the time (2-3 days)
5
Week 3
Did not complete survey
-Week 4
Did not complete survey
-Week 5
Some of the time (2-3 days)
5
Week 6
Some of the time (2-3 days)
7
b
Participant Two
Survey
App Use (Average days per week)
Minutes per use
Week 1
A moderate amount of the time (4-5
5
days)
Week 2
Did not complete survey
-Week 3
Did not complete survey
-Week 4
A moderate amount of the time (4-5
5
days)
Week 5
Did not complete survey
-Week 6
Some of the time (2-3 days)
2
c
Participant Three
Survey
App Use (Average days per week)
Minutes per Use
Week 1
Some of the time (2-3 days)
10
Week 2
Some of the time (2-3 days)
10
Week 3
Some of the time (2-3 days)
5
Week 4
Rarely (1 day)
5
Week 5
Some of the time (2-3 days)
5
Week 6
Not at all
0
a Participant one tracked their app use for four out of the six weeks of the intervention.
b Participant two tracked their app use for three out of the six weeks of the intervention.
c Participant three tracked their app use during all six weeks of the intervention.
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As displayed in Table 2, none of the participants engaged with the app daily;
however, two of the three participants used the app two to three days per week, for
approximately 5 minutes during each use. Participants who completed the follow-up
survey indicated they continued to use the app after study completion. One participant
used the app two to three days per week for approximately five minutes each time.
Another participant reported using the app at least one day per week for approximately
five minutes each time.
Assessment Process
Participants were asked to complete the baseline assessment, five weekly surveys,
the post-intervention survey, and the follow-up survey. As presented in Figure 1,
participation in the weekly surveys varied, and the week one survey was the only survey
completed by all three participants. Two out of three participants completed the weeks
two, four, and five surveys, while only one participant completed the week three survey.
There was a 100% completion rate for the post-intervention survey, while only two out of
three participants (67%) completed the follow-up survey. The average completion times
for each survey are presented in Table 3.

Table 3
Survey Completion Times
Survey
Baseline
Week 1
Week 2
Week 3
Week 4
Week 5
Week 6
Week 10

M (in minutes)
37.19
1.91
1.45
1.03
1.31
1.13
19.41
12.18

SD
20.78
0.89
0.31
-0.22
0.08
3.51
0.56
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Unexpected Barriers to Screening and Recruitment
As previously mentioned, 5.33 patients were screened per month, which was
lower than anticipated. There were several unexpected barriers to screening and enrolling
patients throughout the recruitment process. The first barrier was accessing potentially
eligible patients. Members of the research team were not granted access to this
institution's electronic medical record (EMR) system. Therefore, we were not able to
prescreen and identify potentially eligible patients before going to the clinic. To
overcome this barrier, both of our collaborators, who are providers within the Department
of Family Medicine, prescreened potential participants at the beginning of the week for
the research assistants to approach.
A second barrier was achieving a steady referral rate from residents and
providers. A handout was created and provided to residents and providers (see Appendix
C for a copy of the handout). The handout explained the purpose of the study and the
eligibility criteria. Additionally, each week the research assistants would make their
presence known to the providers and residents and remind them about the research study.
However, members of the research team only received five direct referrals from providers
and residents. This could be further explained by the fact that the resident schedules
would change every four weeks, and/or a new set of residents would come to the clinics.
The research team members would then have to introduce the study to the new residents
or review the study protocol and eligibility criteria with the previous residents.
The third barrier to recruitment was the number of potential participants to
approach varied at each location. For instance, at one of the locations, research team
members recruited for 32 hours over 7 months and approached 11 patients. At the other
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location, research team members recruited for 90 hours over 7 months and approached 17
patients.
The fourth barrier to recruitment was patients' ability to stay after their
appointments to discuss the research study. To not disrupt clinic flow, research assistants
were asked to approach patients after visiting with their provider. However, many
patients often waited for extended periods of time for their provider, and some would
immediately leave before the research assistants had a chance to approach them. There
were also times when the research assistants would attempt to approach the patients right
after their appointment, and they would state that they could not stay and asked to be
contacted at a later time.
A fifth barrier to recruitment was being unable to contact patients who requested
follow-up calls to learn more about the study. For the six patients who requested followup calls, research team members could not reach those patients despite contacting each
patient four times after the initial meeting. More specifically, six patients were sent one
follow-up email following their appointment. Additionally, a member of the research
team called each patient three times on three separate occasions and left voicemails when
possible. These patients did not return any phone calls or emails.
The sixth barrier to recruitment was the availability of research staff to assist with
the recruitment process. The doctoral-level student was available for recruitment sixteen
hours per week. The undergraduate and post-baccalaureate research assistants were each
available for recruitment four hours per week and predominantly recruited alongside the
doctoral-level student. Additionally, during December and January, when the doctoral
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level student was interviewing for predoctoral internship positions, recruitment occurred
twice.
A final barrier to recruitment was our eligibility criteria. Of the 35 patients
approached, 45.7% (n=16) were ineligible, suggesting that our initial criteria were too
restrictive. As seen in Figure 1, the most common reasons participants were not eligible
to participate in this study were because they did not own an iPhone (n=5), were currently
engaged in psychotherapy (n=3), and they endorsed item 9 (i.e., thoughts that you would
be better off dead, or thoughts of hurting yourself in some way) on the PHQ-9 (n=3).
Changes Made to Accelerate Recruitment
To accelerate recruitment, two modifications were made to the initial research
protocol. The first modification was made two months after recruitment began and
incorporated the use of flyers advertising the study. Flyers were displayed in examination
and waiting rooms (see Appendix D for a copy of the flyer). Additionally, primary care
providers could refer patients to the study coordinator. The second modification was
made seven months into recruitment and including advertising the study on the
Department of Family Medicine's Facebook page (see Appendix E for the Facebook
advertisement). Interested patients were directed to a link to the prescreening survey,
which consisted of the PHQ-8 and was administered through Qualtrics. Those who were
eligible to participate were contacted via phone or email within 24-hours to schedule an
in-person meeting with the study coordinator to complete the recruitment and consent
process.
An additional change that was made during the second modification was related
to the eligibility criteria. The initial criterion appeared too restrictive, given that 50% of
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the patients approached were deemed ineligible. Thus, it was decided to expand the
eligibility criteria. Since two of the three mobile apps were available across all platforms
(i.e., MoodTools and Mindfulness Coach) and no participants were randomized to the
application that was only available on the iOS platform, it was decided to remove the
MovingForward app from randomization. We also expanded the PHQ-9 inclusion criteria
to include participants who scored between a five and twenty-four on the PHQ-9.
However, due to the COVID-19 pandemic, recruitment for this study prematurely ended
on March 12, 2020, and we were unable to assess to what extent the proposed changes
would accelerate the recruitment process.
Acceptability
Participants answered six Likert scale questions about their willingness to
participate in the study again, satisfaction with the application, perceived effectiveness,
the likelihood of participating in the study again, whether they would recommend the
application to a friend or family member with depression, and level of confidence
regarding future use of the application and use of specific skills. Results from the
acceptability survey are presented in Table 4.

Table 4
Program Evaluations
Survey Item

Participant One

Participant Two

How likely would you
be to participate in this
study again?

Somewhat likely

Extremely unlikely Somewhat likely
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Participant Three

Survey Item

Participant One

Participant Two

Participant Three

How satisfied are you
with the mobile
application you
worked with?

Somewhat
satisfied

Somewhat satisfied

Very satisfied

Would you
recommend this
mobile application to
a friend or family
member with
depression?

Yes, I would
recommend it
with some
hesitation

Yes, I would
strongly
recommend it

Yes, I would
strongly
recommend it

How well do you
think you would have
managed your
depressive symptoms
during these 6 weeks
without the mobile
application?

Slightly better

Slightly better

Slightly better

How effective was the Neither effective
mobile application at nor ineffective
helping you with your
depression?

Somewhat effective

Somewhat effective

How often did you
use the skills
suggested by the
mobile application?

Once a week

2-3 times per week

Once a week

How confident did
you feel using the
skills that were
presented in the
mobile app to manage
depressive
symptoms?

Neither confident Somewhat
or not confident
confident

Please indicate how
Neither likely
confident you are that, nor unlikely
over the next three
months, you will
continue to use the
mobile application?

Somewhat likely
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Somewhat
confident

Somewhat likely

Participant feedback varied regarding views on satisfaction with the app, as
participants one and two reported that they were "somewhat satisfied." Participant three
endorsed being "very satisfied" with the mobile app. Despite some variability in
satisfaction with the app, all participants reported that they would recommend the app to
a friend or family member with depressive symptoms; however, all participants reported
that they believe they would have managed their depressive symptoms "slightly better"
without the mobile app. Additionally, participants two and three reported the apps were
"somewhat effective" in helping them manage their depressive symptoms. Participant one
reported the app was "neither effective nor ineffective".
Acceptability was also assessed through the use of open-ended questions.
Participants were asked to indicate factors they liked most and least about participating in
the study and the specific features of the app they liked most and least. They were also
asked about how the mobile app helped them manage depressive symptoms and what, if
anything, they believed they still need help with related to managing their depressive
symptoms.
Qualitative feedback showed that participants two and three reported they liked
the mobile apps the most, and participant one liked having their depressive symptoms
normalized. The factor participants one and two liked least about the study was "having
to complete the surveys." Additionally, participants two and three reported that "time"
would be the only factor influencing their decision to participate in this study again.
Regarding the mobile apps' specific features, participant one stated that they liked
"how easy it is to use the app and how convenient it was having it on my phone."
Participant two reported they liked the mindfulness of breath exercise the best, while
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participant three stated, "I like how you talk yourself through a bad thought. This made
me start to do it automatically without needing the app." Regarding features of the app's
participants liked the least, participants two and three did not have any feedback, while
participant one reported that they "wished there were less options to choose from."
In terms of the specific ways the mobile app helped them manage their symptoms,
participant one stated, "it helped me realize that my symptoms are normal and other
people have them, I'm not the only one." Participant two reported that the app was
relaxing and calming, while participant three stated, "when I had a negative thought, I
thought about the app and how I may be overreacting and such." Regarding continued
depressive symptom management, participant one reported "I feel like I'm getting a better
grasp on it," participant two reported they need help "lowering stress," and participant
three stated "getting motivated to get up and move and not just sit around all day."
Treatment Preference
Preference for the type of mobile app was assessed by first providing participants
with a brief overview of problem-solving therapy, cognitive-behavioral therapy, and
mindfulness. They were then asked to indicate which of those treatments they would
prefer and the strength of that preference on a 5-point Likert scale ranging from 1 (Not
strong) to 5 (Very strong). Preference data is available for two out of the three
participants, as one participant skipped this item. Participants two and three answered the
preference questions identically. Both participants indicated a moderately strong (i.e.,
rating of a 3 out of 5 on the Likert Scale) preference for Cognitive Behavioral Therapy.
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Treatment Progress & Outcomes
Participant One
Depression. When participant one completed the PHQ-9 in the office, with the
CMA administering it, they endorsed a score of six, while their baseline PHQ-8 score
was a two. During the six-week period, participant one experienced an eight-point
increase in depressive symptoms. See Figure 2 for participant one's PHQ-8 scores
throughout the study.

Figure 2
Participant One: PHQ-8 Total Scores
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Quality of Life. Participant one's SF-36-SF scores are displayed in Figures 3 and
4. During the six-week intervention period, participant one experienced a decline in
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physical functioning, as evidenced by a 15-point decrease in their scores on this subscale
(please see Figure 3). However, participant one reported an improvement in energy level
and fatigue (see Figure 3) and overall health (see Figure 4) during the intervention period.

Figure 3
Participant One: SF-36 Total Scores, Role Functioning and Fatigue
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Figure 4
Participant One: SF-36 Total Scores, Social and Overall Health
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Health Care Utilization. Participant one did not attend any medical
appointments throughout the study period.
Participant Two
Depression. Participant two's prescreen PHQ-9 score, and baseline PHQ-8 scores
were a 10. During the six-week period, participant two experienced a four-point decrease
in depressive symptoms. On the follow-up survey, participant two reported a two-point
increase in depressive symptoms, resulting in a PHQ-8 score of 8; however, their final
PHQ-8 score remained two points lower than the score reported at baseline. Participant
two's PHQ-8 scores throughout the study are presented in Figure 5.
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Figure 5
Participant Two: PHQ-8 Total Scores
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Quality of Life. Participant two's SF-36-SF scores are displayed in Figures 6 and
7. During the six-week intervention, participant two experienced a decline in physical
functioning (a 30-point difference in scores; see Figure 6), role limitations due to
emotional problems (a 100-point difference in scores; see Figure 6), energy and fatigue
(30-point difference in scores; see Figure 6), and general health (5-point difference; see
Figure 7). However, they did experience an improvement in role limitations due to
physical functioning (25-point increase; see Figure 6), emotional well-being (8-point
increase; see Figure 7), social functioning (13-point increase; see Figure 7), and pain (23-
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point increase; see Figure 7) over the course of the intervention. At the follow-up survey,
participant two reported a decline in scores on the following subscales: physical
functioning (10-point decrease see Figure 6), emotional well-being (8-point decrease, see
Figure 7), pain (20-point decrease, see Figure 7), and general health (12-point decrease,
see Figure 7). They endorsed an improvement in role limitations due to emotional
problems (100-point increase, see Figure 6) and energy and fatigue (10-point increase,
see Figure 6).

Figure 6
Participant Two: SF-36 Total Scores, Role Functioning and Fatigue
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Figure 7
Participant Two: SF-36 Total Scores, Social and Overall Health
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Health Care Utilization. Participant two attended five medical appointments
during the 10-week period, which includes both specialty and family medicine care. The
reasons for all appointments included either getting a "check-up" or refilling
prescriptions.
Participant Three
Depression. At the prescreen, participant three endorsed a score of 10 on the
PHQ-9; however, they endorsed a score of 17 when completing the PHQ-8 at baseline.
During the six-week period, participant three experienced a four-point decrease in
depressive symptoms, resulting in a PHQ-8 score of 13. On the follow-up survey,
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participant three reported a two-point decrease in depressive symptoms, resulting in a
final PHQ-8 score of 11. Participant three's PHQ-8 scores throughout the study are
presented in Figure 8.

Figure 8
Participant Three: PHQ-8 Total Scores
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Quality of Life. Participant three's SF-36-SF scores are displayed in Figures 9
and 10. During the 6-week intervention, participant three experienced an improvement in
role limitations due to emotional problems (33-point increase, see Figure 9), energy and
fatigue (15-point increase, see Figure 9), emotional well-being (40-point increase, see
Figure 10), and social functioning (13-point increase, see Figure 10). They experienced a
decline in scores on the role limitations due to physical functioning subscale (25-point
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decrease, see Figure 9) and no changes in scores on the physical functioning (see Figure
9) and pain subscales (see Figure 10). At the follow-up survey, improvements in role
limitations due to emotional problems (see Figure 9) remained. They also experienced an
improvement in energy and fatigue (5-point increase, see Figure 9) and role limitations
due to physical functioning (25-point increase, see Figure 9). However, they did
experience a decline in scores on the following subscales: emotional well-being (20-point
decrease, see Figure 10) and social functioning (13-point decrease, see Figure 10). Their
scores on the general health subscale did not change from the post-intervention survey to
the follow-up survey (see Figure 10).

Figure 9
Participant Three: SF-36 Total Scores, Role Functioning and Fatigue
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Figure 10
Participant Three: SF-36 Total Scores, Social and Overall Health
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Health Care Utilization. Participant three attended two medical appointments
during the 10-week period, which also included specialty and family medicine care. The
reasons for all appointments included either getting a "check-up" or refilling
prescriptions.
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Chapter 4
Discussion
The primary aim of this study was to evaluate the feasibility and acceptability of
three mobile apps designed to ameliorate depressive symptoms within primary care. The
secondary aim was to examine whether mobile app use would reduce depressive
symptomology and improve quality of life. The insights gained from this study were
examined in order to inform future, larger scale studies in this area. The following is a
review the major themes of study regarding feasibility and acceptability, discussion of the
study limitations, and implications for future directions of research.
Feasibility
Feasibility outcomes included recruitment, randomization, retention, assessment
procedures, and participant engagement with the mobile apps. Recruitment proved to be
most challenging. There were two main factors that interfered with the successful
recruitment of participants. One was the limited number of patients we were able to
approach and the second was the initial eligibility criteria.
Access to Patients
It is possible that the recruitment challenges faced could be best explained by
issues related to the number of patients we were able to approach. Over the course of
seven months and 122 total hours of recruitment, only 35 patients were approached or
contacted about the study. Due to the low volume of patients approached during the first
few months of recruitment, several attempts were made to improve recruitment efforts,
including advertising the study via flyers posted in the waiting room and exams room,
advertising the study on the Department of Family Medicine’s Facebook page, and
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receiving referrals from physicians. In addition, a handout, which explained the purpose
of the study and eligibility criteria, was given to providers. Each week the research
assistants would also make their presence known to the providers and residents and
remind them about the research study. The data demonstrates these efforts did not
drastically improve the number of patients we had access to, as we only received five
referrals from providers and six referrals from the Facebook post and waiting/exam room
flyers.
The final modification made to improve recruitment included removal of the iOS
specific app and expansion of PHQ-9 inclusion criteria to include scores ranging from
five to twenty-four. While the COVID-19 pandemic impacted our ability to assess
whether this modification would have accelerated recruitment, difficulty recruiting within
primary care is a commonly cited problem within the literature (Bell-Syer & Moffett,
2000; Chew-Graham et al., 2007; Johnston et al., 2010; Kaur et al., 2012; Malhotra et al.,
2017). For example, barriers to recruitment have included lack of staff and training,
provider time constraints and heavy workload, provider difficulties remembering
eligibility criteria, concerns about the demands of the research on the patient, worry about
the efficacy of the treatment, interruption of patient flow, lack of familiarity of research
objects, forgetfulness, and clinical relevance of the research (Bell-Syer & Moffett, 2000;
Kaur et al., 2012). The literature also suggests several strategies to improve recruitment
rates, including use of physician recruiters, having an in clinic “champion” for the
research project, minimizing the burden of participation on the practice, have clear and
simple eligibility criteria, and building personal connections with the providers and staff
within the clinics (Johnston et al., 2010). Although much of this research is from the
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United Kingdom, these recruitment insights are applicable to this study based in the
northeastern United States.
Eligibility Criteria
The results indicated the initial eligibility criteria were too restrictive. About 47%
of participants approached did not meet initial eligibility criteria. This was a surprising
outcome given our eligibility criteria were similar to other studies with better enrollment
rates (Arean et al. 2016; Dahne et al., 2019; Moberg et al., 2019; Pratap et al. 2018;
Roepke et al., 2015). The three most frequent reasons participants were not eligible to
participant were because they did not own an iPhone (n=5), endorsed a score of one or
higher on item 9 on the PHQ-9 (i.e., how often have you been bothered by thoughts that
you would be better off dead, or of hurting yourself; n=3), or were currently engaged in
psychotherapy (n=3).
The decision to exclude Android and other smart phone owners was due to one of
the mobile apps (MovingForward) only being available on iOS platforms. Previous
studies overcame this barrier by providing participants with an iPhone or other iOS
products (e.g., Dahn et al., 2019). This approach was not possible for our research study
due to insufficient funding. However, providing mobile devices to suit desired app
platforms may be an alternative for future larger scale studies with increased budgets for
such allocations. Given the fact that approximately 47% of all smartphone users in the
United Stated own an Android smartphone (Statisa, 2021), it may be more feasible and
fiscally responsible for future researchers to identify and evaluate mobile apps that are
common across all platforms.
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In addition, participants who endorsed a score of one or higher on item 9 on the
PHQ-9 were excluded because the research team was not able to screen and track risk
over time. The exclusion of participants indicating risk of self-harm or suicide is
consistent with previous studies (Arean et al., 2016; Dahne et al., 2019). However, it is
worth noting the face validity of this item does not extend to the evaluation or assessment
of suicidal ideation, but rather morbid thoughts or thoughts of self-harm. Therefore, it is
worth questioning whether this criterion for exclusion should be used in future studies
without further assessment for suicidality or other risk factors, such as prior suicide
attempts, misuse and abuse of alcohol or substances, and access to lethal means (Suicide
Prevention Resource Center, 2021).
Several studies have examined the relationship between endorsement of item 9
and suicidal ideation, plan, and attempts. Na and colleagues (2018) examined the positive
predictive value, sensitivity, and specificity of item 9 on the PHQ-9 when compared to
assessment of suicidality using the Columbia Suicide Severity Rating Scale (C-SSRS).
Results indicated that approximately 41% out of 841 patients were identified as being
suicidal through the PHQ-9 compared to 13.4% of patient who completed the C-SSRS.
The authors concluded that item 9 on the PHQ-9 has low positive predictive validity and
specificity, which suggests that this item is an inadequate assessment tool for suicidality.
Corson et al. (2004) evaluated the proportion of primary care patients who would screen
positive for depression and suicidality using the PHQ-2, the PHQ-9, and a structured
clinical interview. Out of 962 primary care patients, 7% reported thoughts of death or
suicide, 2% reported thoughts of self-harm, and 1% reported having a specific plan for
suicide. Additionally, the authors found that approximately one third of the patients who
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endorsed item 9 reported active suicidal ideation. Razykov et al. (2012) found that 110
(10.8%) out of 1,022 coronary artery disease patients endorsed a score of 1 or higher on
item 9. Of those 110 patients, 22 (19.8%) reported suicidal ideation and 9 (8.1%) reported
thinking about a specific plan to commit suicide in the last year. Walker et al. (2011)
evaluated the nature of thoughts of death and suicide in a sample of oncology patients
who endorsed item 9 on the PHQ-9. Results indicated that two thirds of the sample
(n=330) who endorsed item 9 denied any thoughts that they would be better off dead or
endorsed morbid thought but denied suicidal ideation on follow up. Results of these
studies suggest endorsement of item 9 may not warrant immediate exclusion from
participation in the study. Rather, item 9 should be utilized in conjunction with additional
risk assessment tools to accurately assess for eligibility.
Retention
Despite the issues encountered during recruitment, retention was high across the
study duration. All three participants completed the post-intervention survey, and two of
the three participants completed the follow-up survey. Additionally, participants were
engaged with the app throughout the study duration, with all three participants reporting
they used the app on average one to three times per week across the 6-week intervention
period. Two out of the three participants reported continued use at the follow-up survey.
It is possible that our retention and engagement rates were high due to our initial
recruitment efforts of participants. In the current project, participants were recruited inperson, and a member of the research team spent approximately ten minutes showing
participants how to use the app and answering questions about the app. Additionally,
participants were provided with a link to a YouTube video reviewing the features of the
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app. Furthermore, participants were sent weekly surveys inquiring about their app use
and current depressive symptoms, potentially serving as reminders to engage with the
app. Participants also were informed of their ability to contact the study coordinator via
email at any time with questions about app or their participation in the study. These
efforts are consistent with previous literature that has found lower retention rates in trials
where participants were required to have either a telephone or in-person interview or
meeting with the research staff (Linardon & Fuller-Tyszkiewicz, 2019). Additionally,
trials that offer monetary incentives, reminded participants to engage with the mobile
app, offer feedback from research team members, and incorporate some level of mood
monitoring produce significantly lower attrition rates when compared to studies that do
not employ those strategies (Linardon & Fuller-Tyszkiewicz (2019; Torous et al., 2020).
Clearly, we cannot make generalizable conclusions or comparisons regarding
retention due to the sample size of three participants. Retention rates may continue to be a
challenge for mobile app research as recent studies report high attrition rates and lower
levels of engagement with mental health apps (Arean et al., 2016; Pratap et al., 2018). For
example, Baumel et al. (2019) analyzed data from 93 mental health apps and found that
90% of users abandoned apps within ten days of installation. Linardon & FullerTyszkiewicz (2019) conducted a meta-analytic review of randomized controlled trials of
mHealth interventions and found that the mean percentage of complete protocol
adherence amongst depression specific apps were 34% and the percentage of participants
who did not download the app or engage with the app was approximately 41%. Their
findings also suggest that on average one quarter of participants drop out of trials within
the first eight weeks and up to one third drop out of trials that require participant for
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longer than eight weeks. As noted above, our results suggest concerted efforts during
initial recruitment shows promise in addressing retention issues. It would be wise for
larger scale studies to develop multiple ways to engage participants such as userinstructions (i.e. handouts, YouTube videos) as well as in-person and “remote” check-in
for additional support. This front-end approach may help participants feel comfortable
with app, identify and address barriers (e.g. technical issues with app), and increase
engagement.
Acceptability
Acceptability regarding the use of mobile apps was also examined and results
indicate contradictory results. Specifically, participants indicated they were somewhat to
very satisfied with the mobile app. Two participants rated that the app was somewhat
effective at helping them with their depressive symptoms, while one participant indicated
that it was neither effective nor ineffective. However, all three participants reported they
would have been able to manage their depressive symptoms slightly better without the
mobile app. The fact that participants endorsed benefit from the app yet believed they
would manage symptoms slightly better is an important finding. One possible explanation
is related to the content validity of this question (How well do you think you would have
managed your depressive symptoms during these 6 weeks without the mobile
application?) and that it is not assessing the construct that it was intended to measure of
perceived effectiveness of the app. Another possible explanation is the first few times
participants engaged with the app, they found it to be particularly useful as each app
incorporated a psychoeducational and self-monitoring component. Perhaps, as
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participants continued to engage with the app, they found it less helpful leading to the
belief they would have managed their symptoms of depression better without the app.
Treatment Progress & Outcomes
The secondary aim was to examine whether participants utilizing a mobile
application would experience a reduction of depressive symptomology and improvements
in quality of life. The results indicate that two out of the three participants experienced a
reduction of depressive symptoms at the post-intervention survey, and the improvement
remained stable for those two participants at the follow-up survey. Additionally, all three
participants reported improvements in certain areas of quality of life, such as energy
level, fatigue, and emotional well-being at the post-intervention survey. These results are
consistent with previously literature that show mobile app use can reduce depressive
symptoms (Arean et al., 2016; Firth et al., 2017; Ly et al., 2013; Pratap et al., 2018). Due
to the small sample size and our inability to use inferential statistics, we are unable to
firmly state whether these changes were due to their engagement with the mobile apps or
external factors. The lack of efficacy data is a major problem within mental health app
research, as the number mental health apps significantly outweighs the available research
supporting the efficacy of apps as a whole (Neary & Schueller, 2018). Increase research
and clinical trials along with transparent efficacy data are needed so that healthcare
providers can recommend evidence-support mental health apps that suite the unique
mental health needs of the patients they care for.
Limitations & Future Directions
The challenges encountered during enrollment of this study provided key insights
and valuable lessons that could be applied to future research. As previously mentioned, it
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is vital to establish and maintain a collaborative relationship with the entire primary care
staff prior to attempting to recruit research participants. In hindsight, one of the biggest
limitations of this project was the research team not building stronger personal
connections with the providers prior to implementing the protocol. It may have been
advantageous to regularly attend the Department of Family Medicine faculty meetings to
not only introduce the study protocol, purpose, and eligibility criteria, but to also build
relationships with the providers to address questions, discuss their concerns, and assess
their interest in collaborating on this project. This would also serve as an opportunity to
have regular contact with the providers throughout the recruitment process to provide
recruitment updates, challenges, and reminders, which would be consistent with the
recommendations of Ash et al. (2000) and Shelton et al. (2002). Future research should
focus on aspects of feasibility such as patient-flow, provider-time demands, and
comfortability with mobile apps. Future research on implementation of app-based
interventions may wish to explore facilitators and barriers within clinical environments
including timeliness (e.g., implementing within a busy clinical environment) and provider
knowledge about applications.
Additionally, research aimed at better understanding acceptability through the use
of standardized measures is warranted. A limitation of our design is that a threshold for
acceptability was not predetermined prior to study enrollment. This makes it challenging
to provide meaningful conclusions regarding acceptability. The heterogeneity of defining
and assessing acceptability of mental health apps appears to be a common problem within
the mobile app literature and studies often rely on custom, subjective scales to measure
satisfaction and acceptability rather than preexisting standardized assessment tools (Ng et
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al., 2019). In future studies, it will be important to not only provide an operational
definition of acceptability and satisfaction at the beginning of the study, but to also utilize
preexisting standardized assessments to evaluate user engagement indicators of mental
health apps. This will allow comparison of results across studies to better understand
potential challenges around usability and engagement with mental health apps.
While this study had high retention rates, we cannot make generalizable
conclusions or comparisons due to the sample size. It is clear that retention and
engagement will continue to be a central challenge for mobile app research. As a result, it
is critical for future studies to further assess factors that may influence adherence, such as
real-world engagement with apps, digital health literacy, and patient preferences.
Increased contact with study team members in order to help participants navigate the app
or provide a reminder to use it may prove effective to increase adherence. This is
consistent with the research on guided versus unguided self-help interventions, which
suggests that guided self-help interventions are more effective than unguided
interventions (Andersson & Cuijpers, 2009; Richards & Richardson, 2012). Additionally,
future studies may want to explore patient expectations, needs, and attitudes towards
mHealth apps. A qualitative study of the mindfulness app Headspace found that barriers
to utilizing the app included difficulty finding time, negative expectations about
mindfulness, negative experiences using the app, the opinions of other people, and
uncomfortable emotions (Laurie & Blandford, 2016). Future research efforts in mobile
apps might consider user end perspectives (e.g., attitudes about mobile apps), research
methodology (e.g., reminders and in-person meetings with study team members), and
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real-world factors (e.g., time limitations and barriers). Implementing this type of
multidimensional approach may aid in reducing issues of retention in mobile health apps.
Lastly, COVID-19 has resulted in a tremendous increase in the use of digital
mental health tools within healthcare. The level of engagement and incorporation of
digital mental health tools will likely continue beyond the COVID-19 pandemic. It is
vital for future research to ensure that these tools are safe and effective for users. Inkster
and colleagues (2020) highlight the importance of increasing access to digital healthcare,
including converting conventional mental health services and resources to mobile apps
and digital formats, making higher-quality mobiles apps available for free, and creating a
data repository in order for researchers to understand mobile apps effectiveness across
socio-cultural demographics. The contributing factors explored in this research regarding
feasibility and acceptability require additional exploration for population sub-groups to
address mental health concerns in primary care.
Conclusion
This study provides keys insights and important lessons from attempting to
implement a randomized controlled trial within a primary care setting. Given the results
of this study and previous literature, the future of mobile app research is contingent upon
understanding factors that influence user engagement with apps. Addressing the
aforementioned limitations will shed light on the ways in which user engagement, patient
expectancy effects, and clinical environments influence intervention outcomes.
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Appendix A
Acceptability Measure
The following questions will ask you about your use and satisfaction with the mobile
application used during this study.
1. How likely would you be to participate in this study again?
o Extremely unlikely (1)
o Somewhat unlikely (2)
o Neither likely nor unlikely (3)
o Somewhat likely (4)
o Extremely likely (5)
2. What did you like most about participating in this study?
________________________________________________________________
3. What did you like least about participating in this study?
________________________________________________________________
4. What factors might impact your decision to participate again?
________________________________________________________________
5. How satisfied are you with the mobile application you worked with?
o Not at all satisfied (1)
o Somewhat unsatisfied (2)
o Neither satisfied nor unsatisfied (3)
o Somewhat satisfied (4)
o Very satisfied (5)
6. What specific features of the mobile application did you like the most?
________________________________________________________________
7. What specific features of the mobile application did you like the least?
________________________________________________________________
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8. Would you recommend this mobile application to a friend or family member with
depression?
o No, I would not recommend it
o I am not sure
o Yes, I would recommend it, with some hesitation
o Yes, I would strongly recommend it
9. How well do you think you would have managed your depressive symptoms during
these 6 weeks without the mobile application?
o Much better (1)
o Slightly better (2)
o About the same (3)
o Slightly worse (4)
o Much worse (5)
10. How effective was the mobile application at helping you with your depression?
o Not at all effective (1)
o Somewhat not effective (2)
o Neither effective nor ineffective (3)
o Somewhat effective (4)
o Very effective (5)
11. How often did you use the skills suggested by the mobile application?
o Never
o Once a week
o 2-3 times a week
o 4-6 times a week
o Daily
12. How confident did you feel using the skills that were presented in the mobile app to
manage depressive symptoms?
o Very confident (1)
o Somewhat confident (2)
o Neither confident or not confident (3)
o Somewhat not confident (4)
o Not at all confident (5)
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13. Please indicate how confident you are that, over the next three months, you will
continue to use the mobile application?
o Extremely likely (1)
o Moderately likely (2)
o Slightly likely (3)
o Neither likely nor unlikely (4)
o Slightly unlikely (5)
o Moderately unlikely (6)
o Extremely unlikely (7)
14. Could you provide any specific comments about the ways in which the mobile
application helped you manage your depressive symptoms?
________________________________________________________________
15. If you were able to add anything to the app to make it more helpful, what might you
add? (State "nothing" if there is nothing you would add).
________________________________________________________________
16. What, if anything, do you feel you still need help with related to managing depressive
symptoms?
________________________________________________________________
17. Is there anything else you can tell us about the features, layout, or other design
aspects of the app that you have found to be either helpful or problematic? (State
"nothing" if there is nothing else you want to tell us).
________________________________________________________________
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Appendix B
Health Service Utilization Measure
The questions below are going to ask you about your use of health care services in the
past month.
1. In the past month, how many times did you go to a doctor, nurse, or other health
professional to get care for yourself?
o None
o One time
o Two times
o Three times
o Four times
o Five or more times
2. What was the purpose of the visit?
________________________________________________________________
3. In the past month, how many times have you visited your primary care provider at
Rowan Family Medicine for a health concern?
o None
o One time
o Two times
o Three times
o Four times
o Five or more times
4. What was the purpose of the visit?
__________________________________________________________
5. In the past month, have you seen a psychiatrist to discuss and/or receive medications
for mental health concerns?
o Yes
o No
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7. In the past month, how many times did you use psychiatric services?
o None
o One time
o Two times
o Three times
o Four times
o Five or more times
8. What was the purpose of the visit?
________________________________________________________________
9. In the past month, did you visit the emergency room?
o Yes
o No
10. In the past month, how many times did you visit the emergency room?
o None
o One time
o Two times
o Three times
o Four times
o Five or more times
11. What was the purpose of the visit?
________________________________________________________________
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Appendix C
Provider Handout

Mobile Apps in Primary Care
Brief Project Description
The goal of this study is to test the feasibility, acceptability, and preliminary effectiveness of mobile
applications for depression. Patients will be randomized to one of four conditions: a) a cognitive behavioral
therapy app, b) a problem-solving therapy app, c) a mindfulness-based app, or d) the waitlist control condition.

We are looking for patients who:
1) are 18 years of age or older
2) have a known history of depression AND/OR score between 5 and 14 on the PHQ-9
2a) Patients must score a 0 on question 9 of the PHQ-9.

Mobile Apps in Primary Care
Brief Project Description
The goal of this study is to test the feasibility, acceptability, and preliminary effectiveness of mobile
applications for depression. Patients will be randomized to one of four conditions: a) a cognitive behavioral
therapy app, b) a problem-solving therapy app, c) a mindfulness-based app, or d) the waitlist control condition.

We are looking for patients who:
1) are 18 years of age or older
2) have a known history of depression AND/OR score between 5 and 14 on the PHQ-9
2a) Patients must score a 0 on question 9 of the PHQ-9.

Mobile Apps in Primary Care
Brief Project Description
The goal of this study is to test the feasibility, acceptability, and preliminary effectiveness of mobile
applications for depression. Patients will be randomized to one of four conditions: a) a cognitive behavioral
therapy app, b) a problem-solving therapy app, c) a mindfulness-based app, or d) the waitlist control condition.

We are looking for patients who:
1) are 18 years of age or older
2) have a known history of depression AND/OR score between 5 and 14 on the PHQ-9
2a) Patients must score a 0 on question 9 of the PHQ-9.
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Appendix D
Flyer For Waiting and Exam Rooms

If you are at least 18 years old and own an iPhone,
this study may be for you.
Location

Study for Adult Patients of Rowan
Family Medicine with Depression

You only need to meet with a member
of the research team once! This will
happen after your appointment with
your doctor. All other study activity
will take place online.

We are looking for adults (18 years
and older) who experience
depression and are a patient of one
of the Rowan Family Medicine
offices to examine whether we can
use mobile applications to
effectively treat depressive
symptoms.

Are you eligible?
• Are you 18 years old or older?
• Do you own an iPhone?
• Are you experiencing symptoms of
depression?
If you’re unsure if you meet the
requirements, email or call the study
coordinator:
• Krista Herbert, MA
• Phone: 609-290-1153
• Email: Herbertk9@rowan.edu

Participants will receive compensation!
Version #: V1
Version Date: 10/18/19
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Appendix E
Facebook Advertisement

Mobile Applications in Primary Care
Are you a patient of Rowan Family Medicine? Are you experiencing symptoms of
depression? If you are 18 years old and over and own an iPhone, this study may be for
you!
We are conducting a study to assess whether we can use mobile applications to treat
depression in primary care. Additionally, we want to see if the use of mobile applications
helps reduce symptoms of depression and improve quality of life. Participation in the
study is completely voluntary.
To find out if you are eligible, please click here:
https://rowan.co1.qualtrics.com/jfe/form/SV_ehw1Lpq0wUbaPzL
This study has been approved by Rowan Universities IRB #Pro2019000363.
For additional information or questions, please contact:
Krista Herbert, MA
Doctoral Student, Clinical Psychology
Psychology Department
Rowan University
Glassboro, NJ 08028
herbertk9@rowan.edu
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